HOPX and lung cancer: We found that there is significant difference (p < 0.05) in methylation levels of B3GAT2, BCAR1, HLF, HOPX, HOXD11, MIR1203, MYL9, SLC9A3R2, SYT5, and VTRNA1-3 between lung cancer patients and healthy individuals (Figure 3).